Evolus, Inc. Share Price: EOLS (Evolus, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Evolus, Inc. share price today?

Accepted Answer

Evolus, Inc. (EOLS) share price today is {{live_price}}.

Question 2

Can Indians buy Evolus, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Evolus, Inc. (EOLS) from India.

With INDmoney, you can buy Evolus, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Evolus, Inc. at zero transaction cost.

Question 3

How can I buy Evolus, Inc. shares from India?

Accepted Answer

It is very easy to buy Evolus, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Evolus, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Evolus, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Evolus, Inc. stocks?

Accepted Answer

To start investing in Evolus, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Evolus, Inc.

Accepted Answer

Today’s highest price of Evolus, Inc. (EOLS) is {{1_rba_end}}.

Today’s lowest price of Evolus, Inc. (EOLS) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Evolus, Inc.

Accepted Answer

Today's market capitalisation of Evolus, Inc. EOLS is 945.2M

Question 8

What is the 52 Week High and Low Range of Evolus, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Evolus, Inc. is down from its 52 Week High?

Accepted Answer

Evolus, Inc. (EOLS) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Evolus, Inc. is up from its 52 Week low?

Accepted Answer

Evolus, Inc. (EOLS) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Evolus, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Evolus, Inc.

Accepted Answer

Mr. David  Moatazedi is the current Chief Executive Officer (CEO) of Evolus, Inc..

Period	Evolus, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	25.83%	5.1%	0.0%
6 Months	-0.54%	4.9%	0.0%
1 Year	50.1%	16.6%	0.0%
3 Years	55.33%	13.2%	-22.3%

Market Capitalization	945.2M
Book Value	$0.31
Earnings Per Share (EPS)	-0.88
Wall Street Target Price	22.43

Profit Margin	-22.43%
Operating Margin TTM	-9.11%

Return On Assets TTM	-9.36%
Return On Equity TTM	-861.68%

Revenue TTM	237.3M
Revenue Per Share TTM	4.03
Quarterly Revenue Growth YOY	35.6%
Gross Profit TTM	92.7M
EBITDA	-24.6M
Diluted Eps TTM	-0.88
Quarterly Earnings Growth YOY	0.0

Evolus, Inc. (EOLS)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Increasing Revenue

Increasing Net Profit

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-0.24
EPS Estimate Next Year	0.16
EPS Estimate Current Quarter	-0.05
EPS Estimate Next Quarter	-0.1

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Evolus, Inc.	13.94%	-0.54%	50.1%	55.33%	-4.04%
Neurocrine Biosciences Inc.	-16.62%	-11.2%	10.78%	28.21%	20.17%
Haleon Plc Spon Ads	7.49%	20.82%	28.48%	39.41%	39.41%
Zoetis Inc.	2.41%	4.25%	0.77%	-8.94%	49.4%
Viatris Inc.	-0.79%	-8.6%	12.7%	-23.12%	-31.03%
Catalent, Inc.	0.82%	6.48%	22.57%	-57.47%	16.16%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Evolus, Inc.	NA	NA	NA	-0.24	-8.62	-0.09	NA	0.31
Neurocrine Biosciences Inc.	36.53	36.53	0.27	4.57	0.16	0.12	NA	24.87
Haleon Plc Spon Ads	33.32	33.32	1.47	0.39	0.07	0.04	0.02	1.82
Zoetis Inc.	36.6	36.6	2.61	5.82	0.49	0.14	0.01	10.94
Viatris Inc.	224.4	NA	0.07	2.68	-0.03	0.03	0.04	16.36
Catalent, Inc.	211.02	NA	2.87	0.2	-0.25	0.0	NA	19.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Evolus, Inc.	Buy	$945.2M	-4.04%	NA	-22.43%
Neurocrine Biosciences Inc.	Buy	$12.2B	20.17%	36.53	16.0%
Haleon Plc Spon Ads	Buy	$47.1B	39.41%	33.32	9.66%
Zoetis Inc.	Buy	$85.7B	49.4%	36.6	26.29%
Viatris Inc.	Hold	$13.5B	-31.03%	224.4	-4.24%
Catalent, Inc.	Hold	$10.9B	16.16%	211.02	-23.81%

Organization	Evolus, Inc.
Employees	304
CEO	Mr. David Moatazedi
Industry	Health Technology